Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. Senator Tommy Tuberville Just Reported a Sale of $AMGN stock

Published 02/15/2024, 11:40 AM
Updated 02/15/2024, 12:00 PM
© Reuters.  U.S. Senator Tommy Tuberville Just Reported a Sale of $AMGN stock

Quiver Quantitative - In a new disclosure filed today, U.S. Senator Tommy Tuberville reported the sale of $15,001 - $50,000 of Amgen Inc (NASDAQ:AMGN). - Common Stock, in a trade that took place on January 19. Since that trade was made, the stock has fallen approximately 6.89%.

Members of Congress have traded $AMGN stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:

- Representative Kathy Manning purchased up to $15,000 on 01/23.

- Senator Tuberville, Tommy sold up to $50,000 on 01/19.

- Representative Michael C. Burgess sold up to $50,000 on 01/02.

- Representative Greg Stanton has traded $AMGN 2 times. They made 1 purchase worth up to $15,000 on 09/26 and 1 sale worth up to $15,000 on 10/24.

$AMGN has disclosed $11,810,000 of lobbying in the last year. To see more information on the specific issues that they were lobbying on, you can visit our lobbying dashboard for $AMGN.

To see more data on trading by politicians, check out our congressional trading dashboard.

This article was originally published on Quiver Quantitative

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.